2015
DOI: 10.5301/ijao.5000405
|View full text |Cite
|
Sign up to set email alerts
|

Labeling and Qualification of Endothelial Progenitor Cells for Tracking in Tissue Engineering: An in Vitro Study

Abstract: It is possible to label human EPCs with TdTomato without affecting their behavior by the transduction procedure. This creates an important tool for numerous applications. Our results provide a qualification of labeled EPCs in comparison with unlabeled ones for vascular and bone tissue engineering.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 24 publications
(48 reference statements)
0
12
0
Order By: Relevance
“…Samples were treated anonymously. HUVECs were transduced with a vector containing the RFP gene under the control of the EF1a promoter following a procedure similar to the one previously described [24]. RFP-labeled HUVECs were cultured in Iscove's Modified Dulbecco's Medium (IMDM, Gibco, Paisley, Scotland, UK) containing 20% fetal bovine serum (FBS, GE Healthcare, Pasching, Austria), 20 μg ml −1 endothelial cell growth supplement, 90 μg ml −1 heparin (ECGS/H 0.4% (v/v); PromoCell, Heidelberg, Germany) and 10% endothelial cell growth medium-2 (EGM-2 MV, Lonza, Walkersville, MD, USA), in a controlled atmosphere (5% CO 2 , 95% relative humidity (RH), 37 °C-incubator (Binder, Germany)).…”
Section: Methodsmentioning
confidence: 99%
“…Samples were treated anonymously. HUVECs were transduced with a vector containing the RFP gene under the control of the EF1a promoter following a procedure similar to the one previously described [24]. RFP-labeled HUVECs were cultured in Iscove's Modified Dulbecco's Medium (IMDM, Gibco, Paisley, Scotland, UK) containing 20% fetal bovine serum (FBS, GE Healthcare, Pasching, Austria), 20 μg ml −1 endothelial cell growth supplement, 90 μg ml −1 heparin (ECGS/H 0.4% (v/v); PromoCell, Heidelberg, Germany) and 10% endothelial cell growth medium-2 (EGM-2 MV, Lonza, Walkersville, MD, USA), in a controlled atmosphere (5% CO 2 , 95% relative humidity (RH), 37 °C-incubator (Binder, Germany)).…”
Section: Methodsmentioning
confidence: 99%
“…Cells were expanded in Iscove's Modified Dulbecco's Medium (IMDM; Gibco, Thermo Fisher Scientific) containing 20% FBS, 12  μ g/mL endothelial cell growth supplement, and 90  μ g/mL heparin (ECGS/H 0.4% (v/v); PromoCell, Heidelberg, Germany) in gelatin-coated (0.2%; Sigma-Aldrich, Saint Quentin Fallavier, France) cell-culture flasks. Passage-1 cells were transduced with a lentiviral vector codding for the tdTomato fluorescent protein [18, 19]. Transduced and untransduced cells were used as stated for each experiment.…”
Section: Methodsmentioning
confidence: 99%
“…Most cell tracking work has centered on imaging modalities such as MRI, radionuclide imaging, and optical imaging. However, X-ray computed tomography (CT) is an emerging method for cell tracking that has several strengths such as high spatial and temporal resolution, and excellent quantitative capabilities [2-4,11,12].…”
Section: Discussionmentioning
confidence: 99%